The Global Postpartum Depression (PPD) Market is projected to grow from USD 8.68 billion in 2023 to USD 55.24 billion by 2031, at a CAGR of 30.25%[1]. The increased prevalence of PPD, which has nearly doubled from 9.4% in 2010 to 19.3% in 2021, highlights the growing recognition and diagnosis of this condition, driving demand for effective treatments such as brexanolone (Zulresso) and innovative therapies[1].
Factors such as decreased stigma around mental health and advancements in treatment options are significantly fueling market growth. However, high treatment costs and inconsistent screening practices are key challenges that can restrict access to effective care[1].[1]
Get more accurate answers with Super Pandi, upload files, personalized discovery feed, save searches and contribute to the PandiPedia.
Let's look at alternatives:
- Modify the query.
- Start a new thread.
- Remove sources (if manually added).
